Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Bacterial Infections and Mycoses

Free Subscription 19.01.2026 1 Am J Med 4 Antimicrob Agents Chemother 1 Chest 5 Clin Infect Dis 5 Curr Microbiol 4 Diagn Microbiol Infect Dis 1 Drugs 2 Eur J Clin Microbiol Infect Dis 4 Infect Immun 13 J Antimicrob Chemother 2 J Bacteriol 3 J Clin Invest 6 J Clin Microbiol 2 J Infect Dis 2 J Med Chem 3 J Med Microbiol 1 Lancet 3 Nat Med 1 Nature 1 PLoS Genet 1 PLoS Med 7 PLoS One 4 PLoS Pathog 4 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. GAGLIO A, Angelone D, Fabozzi A, Bezzio M, et al
   Pulmonary amyloidoma mimicking lung cancer in a patient with previous tuberculosis.
   Am J Med. 2026 Jan 9:S0002-9343(26)00006-9. doi: 10.1016/j.amjmed.2025.
   PubMed        
   
   

   
   Antimicrob Agents Chemother

2. SORDELLO S, Brock L, Tagliavini A, Federico D, et al
   A modeling-based framework to evaluate forgiveness of tuberculosis treatment in a BALB/c relapsing mouse model.
   Antimicrob Agents Chemother. 2026 Jan 15:e0110925. doi: 10.1128/aac.01109.
   PubMed         Abstract available
   
   
3. FERNANDES C, Lemos F, Curado L, Victor BL, et al
   Characterization of a novel monoclonal antibody candidate that targets bacterial GAPDH and protects neonatal mice from infections caused by Streptococcus pneumoniae or Streptococcus agalactiae.
   Antimicrob Agents Chemother. 2026 Jan 14:e0066625. doi: 10.1128/aac.00666.
   PubMed         Abstract available
   
   
4. KUTSCHER HL, Tamblin M, Smith E, Shah A, et al
   Repeated pulmonary dosing of beta-glucan-chitosan-PLGA nanoparticles controls Mycobacterium tuberculosis in mice.
   Antimicrob Agents Chemother. 2026 Jan 14:e0148025. doi: 10.1128/aac.01480.
   PubMed         Abstract available
   
   
5. ANEKE CI, Shahegh SS, Freeman AF, Zerbe C, et al
   Beyond Fumigatus: a molecular portrait of clinical Aspergillus diversity, pathogenicity, and antifungal resistance.
   Antimicrob Agents Chemother. 2026 Jan 13:e0118425. doi: 10.1128/aac.01184.
   PubMed         Abstract available
   
   

   
   Chest

6. METERSKY ML, Hunt CR, Addrizzo-Harris DJ, Aksamit TR, et al
   The Bronchiectasis and Non-Tuberculous Mycobacterial Care Center Network: Improving Access and Quality of Care.
   Chest. 2026;169:34-36.
   PubMed        
   
   

   
   Clin Infect Dis

7. BADDLEY JW, Wolf J, Ardura MI, Badreldin N, et al
   2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) in Adults, Children, and Pregnant People.
   Clin Infect Dis. 2026;81.
   PubMed         Abstract available
   
   
8. PAPPAS P, Lentz RJ, Stover KR, Wiederhold NP, et al
   2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People.
   Clin Infect Dis. 2026;81.
   PubMed         Abstract available
   
   
9. ARNOLD SR, Spec A, Baddley JW, Pappas P, et al
   2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) and Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children,
   Clin Infect Dis. 2026;81.
   PubMed         Abstract available
   
   
10. NIWARD K, Braian C, Svardhagen G, Augustinsson D, et al
    Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management.
    Clin Infect Dis. 2026 Jan 15:ciaf663. doi: 10.1093.
    PubMed         Abstract available
    
    
11. NALUGWA T, Shah KM, Marcelo D, Nakawunde R, et al
    Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries.
    Clin Infect Dis. 2026 Jan 14:ciag022. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Curr Microbiol

12. CHENG H, Qiu J, Ghafar MA, Hussain T, et al
    First Report of Aspergillus aculeatus Colonizing Protaetia brevitarsis Larvae: Pathogenicity and Dose-Dependent Virulence.
    Curr Microbiol. 2026;83:138.
    PubMed         Abstract available
    
    
13. MUKHERJEE DB, Narayanaswamy S, Rangappa NB
    Molecular Kaleidoscope of Nucleoid-Associated Proteins Regulatory Network and Chromosome Architecture in Mycobacterium Tuberculosis.
    Curr Microbiol. 2026;83:135.
    PubMed        
    
    
14. LIM CJJ, Chung HH, Lau MML, Kho CJY, et al
    Isolation of Proteus sp. Closely Related to P. Vulgaris (Vulgaris/hauseri Complex) from Ornamental Koi (Cyprinus rubrofuscus) and its Pathogenicity.
    Curr Microbiol. 2026;83:126.
    PubMed         Abstract available
    
    
15. TUAN DA, Masak J
    Natural-Compound Adjuvants Dismantle Candida Biofilms: Mechanisms, Design Rules, and Biofilm-Aware Pharmacology.
    Curr Microbiol. 2026;83:131.
    PubMed         Abstract available
    
    
16. NISHANT, Chandra S
    Green Synthesis and Bioactivity Evaluation of Silver Nanoparticles from Stevia rebaudiana and the Endophyte Aspergillus versicolor.
    Curr Microbiol. 2026;83:130.
    PubMed         Abstract available
    
    

    
    Diagn Microbiol Infect Dis

17. VALAPALA VNG, Bylapudi P, Poluri LV, Vandana M, et al
    All spinal infections are not always tuberculosis: A rare case of brucella spondylodiscitis in South India.
    Diagn Microbiol Infect Dis. 2026;114:117262.
    PubMed         Abstract available
    
    
18. LIANG Y, Xu L, Liu S, Liang Z, et al
    Clinical and molecular characterization of a fulminant meningococcemia case in an adult caused by Neisseria meningitidis serogroup Y clonal complex 23 strain in China.
    Diagn Microbiol Infect Dis. 2026;114:117242.
    PubMed         Abstract available
    
    
19. ZHU S, Huang X, Lai W, He Y, et al
    Evaluation of rapid point-of-care test based on qPCR for detecting Neisseria gonorrhoeae and beta-lactamase to guide the use of antibiotics.
    Diagn Microbiol Infect Dis. 2026;114:117197.
    PubMed         Abstract available
    
    
20. TSUJI S, Fukushima S, Gotoh K, Iio K, et al
    Molecular epidemiological investigation of the carbapenemase-producing Enterobacterales isolates in Okayama prefecture, Japan.
    Diagn Microbiol Infect Dis. 2026;114:117209.
    PubMed         Abstract available
    
    

    
    Drugs

21. SHIRLEY M
    Aztreonam-Avibactam: A Review in the Treatment of Serious Bacterial Infections Caused by Aerobic Gram-Negative Organisms.
    Drugs. 2026;86:79-91.
    PubMed         Abstract available
    
    

    
    Eur J Clin Microbiol Infect Dis

22. REIZINE F, Mauget M, Massart N, Fedun Y, et al
    Clinical spectrum of ICU-acquired invasive pulmonary aspergillosis according to SARS-CoV2 infection: a multicenter prospective cohort study.
    Eur J Clin Microbiol Infect Dis. 2026 Jan 12. doi: 10.1007/s10096-025-05391.
    PubMed         Abstract available
    
    
23. GUPTA RK, Chauhan K, Singhal R, Anthwal D, et al
    Development and evaluation of 'Quick TB DNA Extraction' kit for the rapid and efficient detection of multidrug-resistant tuberculosis from sputum transported on bio-safe filter.
    Eur J Clin Microbiol Infect Dis. 2026 Jan 12. doi: 10.1007/s10096-025-05312.
    PubMed         Abstract available
    
    

    
    Infect Immun

24. LU S, Yuan S, Liu P, Bai X, et al
    T6SS1 suppresses pro-inflammatory cytokine transcription to drive immune evasion and systemic infection in Vibrio parahaemolyticus.
    Infect Immun. 2026;94:e0058725.
    PubMed         Abstract available
    
    
25. NAWAZ S, Wang Z, Jiang W, Kong L, et al
    Quorum-sensing regulator LsrR modulates avian pathogenic Escherichia coli pathogenicity through direct regulation of cysN.
    Infect Immun. 2026;94:e0042125.
    PubMed         Abstract available
    
    
26. AVINA SL, Pawar S, Kadam RN, Rivera A, et al
    Mannoprotein Cig1 contributes to the immunogenicity of a heat-killed F-box protein Fbp1 Cryptococcus neoformans vaccine model.
    Infect Immun. 2025 Nov 28:e0035525. doi: 10.1128/iai.00355.
    PubMed         Abstract available
    
    
27. WANTUCH PL, Robinson LS, Knoot CJ, Harding CM, et al
    Differential virulence and immune recognition of Klebsiella pneumoniae O-antigen subtypes O2alpha and O2beta.
    Infect Immun. 2026;94:e0053825.
    PubMed         Abstract available
    
    

    
    J Antimicrob Chemother

28. MENDOZA-PALOMAR N, Simo Nebot S, Roig-Soria L, Alonso Garcia L, et al
    Real-life use of isavuconazole in Spanish children and adolescents.
    J Antimicrob Chemother. 2026;81:dkaf394.
    PubMed         Abstract available
    
    
29. SINGH S, Boorgula GD, Nguyen MH, Daley CL, et al
    Preclinical evaluation of epetraborole in the hollow fibre system model of Mycobacterium abscessus lung disease.
    J Antimicrob Chemother. 2026;81:dkaf405.
    PubMed         Abstract available
    
    
30. MUDDE SE, Meliefste HM, Klaassen CHW, Ammerman NC, et al
    Omadacycline as a drug candidate for Mycobacterium avium infections: in vitro insights on single and combination therapies.
    J Antimicrob Chemother. 2026;81:dkaf413.
    PubMed         Abstract available
    
    
31. SHASTRI P, Bains G, Henriksen AS, Karas A, et al
    Coccidioidomycosis in Europe: a systematic literature review of epidemiology, treatment and outcomes.
    J Antimicrob Chemother. 2026;81:dkaf407.
    PubMed         Abstract available
    
    
32. ZHONG Y, Hope W, Buchan I, Velluva A, et al
    Machine learning for personalized antimicrobial susceptibility breakpoints.
    J Antimicrob Chemother. 2026;81:dkaf419.
    PubMed         Abstract available
    
    
33. HUANG Y, Truelson KA, Stewart IA, O'Doherty GA, et al
    Enhanced activity of apramycin and apramycin-based combinations against Mycobacteroides abscessus.
    J Antimicrob Chemother. 2026;81:dkaf433.
    PubMed         Abstract available
    
    
34. PATTERSON-FAHY K, Carter R, Bell SC, Evans IES, et al
    In vitro efficacy of sulbactam/durlobactam combined with beta-lactam antibiotics in Australian Mycobacterium abscessus isolates.
    J Antimicrob Chemother. 2026;81:dkaf441.
    PubMed         Abstract available
    
    
35. MONTERO MM, Fernandez-Munoz A, Domene-Ochoa S, Castaneda S, et al
    Preventing resistance development in infections by OXA beta-lactamase-producing Pseudomonas aeruginosa: correlating clinical outcomes with hollow-fibre model input.
    J Antimicrob Chemother. 2026;81:dkaf464.
    PubMed         Abstract available
    
    
36. AHLSTRAND J, Maatouk I, Doanh LH, Girdthep N, et al
    High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-24.
    J Antimicrob Chemother. 2026;81:dkaf452.
    PubMed         Abstract available
    
    
37. RARO OHF, Findlay J, Poirel L, Decousser JW, et al
    In vitro selection of cefiderocol-resistant mutants in Acinetobacter baumannii harbouring the most common carbapenemase genes.
    J Antimicrob Chemother. 2026;81:dkaf462.
    PubMed         Abstract available
    
    
38. TALIANU A, Fraser-Krauss O, Bolton W, Ming D, et al
    Artificial intelligence for improving decision-making in bacterial infection management: a narrative review.
    J Antimicrob Chemother. 2026;81:dkaf470.
    PubMed         Abstract available
    
    
39. MELIEFSTE HM, Mudde SE, Ammerman NC, Bexkens ML, et al
    Towards enhanced translational value: preclinical drug activity testing against actively multiplying, nutrient-starved and pellicle biofilm-embedded Mycobacterium abscessus.
    J Antimicrob Chemother. 2026;81:dkaf468.
    PubMed         Abstract available
    
    
40. GEORGIOU PC, Siopi M, Tsala M, Lagarde C, et al
    Pharmacodynamic studies of taniborbactam (VNRX-5133) combined with cefepime against beta-lactamase-producing Gram-negative bacteria in a neutropenic murine thigh infection model.
    J Antimicrob Chemother. 2026;81:dkaf431.
    PubMed         Abstract available
    
    

    
    J Bacteriol

41. SMITH V, Farzand R, Chandrasekharan G, Watkins KE, et al
    The staphylococcal type VII secretion system protein EsxC impacts daptomycin sensitivity through controlling bacterial cell envelope integrity.
    J Bacteriol. 2026 Jan 12:e0038025. doi: 10.1128/jb.00380.
    PubMed         Abstract available
    
    
42. CUTTS WD, Flanagan AW, Gorman BK, Sweten A, et al
    CRISPR interference in a Streptococcus agalactiae multi-locus sequence type 17 strain.
    J Bacteriol. 2026 Jan 14:e0037625. doi: 10.1128/jb.00376.
    PubMed         Abstract available
    
    

    
    J Clin Invest

43. ARMSTRONG EM, Mizgerd JP
    Helping alveolar macrophages live to fight another day during viral pneumonia.
    J Clin Invest. 2026;136:e201457.
    PubMed         Abstract available
    
    
44. HOFFMANN K, Behrendt U, Pennitz P, Kirsten H, et al
    Mechanical strain exacerbates Pseudomonas infection in an organoid-based pneumonia-on-a-chip model.
    J Clin Invest. 2025;136:e192454.
    PubMed         Abstract available
    
    
45. MALAINOU C, Peteranderl C, Ferrero MR, Vazquez-Armendariz AI, et al
    TNF superfamily member 14 drives post-influenza depletion of alveolar macrophages, enabling secondary pneumococcal pneumonia.
    J Clin Invest. 2025;136:e185390.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

46. HAAS PD, Kabugo J, Namutebi J, Tiemersma E, et al
    Evaluation of the Simple One-Step (SOS) stool method for Truenat MTB plus and Xpert MTB/XDR assay.
    J Clin Microbiol. 2026;64:e0104025.
    PubMed         Abstract available
    
    
47. LIN Y-T, Lin H-H, Chen C-H, Tseng K-H, et al
    Interpretive agreement of susceptibility between broth microdilution and disk diffusion methods for cefiderocol, using criteria from the Clinical and Laboratory Standards Institute, European Committee on Antimicrobial Susceptibility Testing, and the F
    J Clin Microbiol. 2026;64:e0125525.
    PubMed         Abstract available
    
    
48. LEE E, Jung WS, Lim CS, Jang WS, et al
    Development of a LAMP assay using hybridization-based TaqMan-style probes (HyTaq) for simultaneous detection of wild-type and macrolide-resistant Mycoplasma pneumoniae.
    J Clin Microbiol. 2025 Dec 17:e0129125. doi: 10.1128/jcm.01291.
    PubMed         Abstract available
    
    
49. SIMMONS-WILLIAMS C, Soares L, Becker D, Lima A, et al
    Comparison of the VITEK REVEAL AST and Accelerate Pheno systems for fast antimicrobial susceptibility testing of gram-negative blood cultures at a large academic health system.
    J Clin Microbiol. 2026;64:e0107325.
    PubMed         Abstract available
    
    
50. ZHANG Y, Huo C, Zhang T, Liu Q, et al
    A novel Pyrococcus furiosus argonaute-based method for rapid and sensitive detection of Mycoplasma pneumoniae and a macrolide-resistance-related mutation.
    J Clin Microbiol. 2025 Dec 18:e0108925. doi: 10.1128/jcm.01089.
    PubMed         Abstract available
    
    
51. HOFFMANN H, Golubov A, Corbett C, Allamuratova D, et al
    Tuberculosis diagnosis and the complete drug resistance pattern from a single sample within a single day by use of a composite platform of MAX MDR-TB and AmPORE-TB.
    J Clin Microbiol. 2026 Jan 12:e0138825. doi: 10.1128/jcm.01388.
    PubMed         Abstract available
    
    

    
    J Infect Dis

52. LIBBY TE, Karani A, Tickell KD, Akech D, et al
    The effect of a 5-day course of azithromycin on Streptococcus pneumoniae carriage and antimicrobial resistance among Kenyan children discharged from hospital.
    J Infect Dis. 2026 Jan 16:jiag028. doi: 10.1093.
    PubMed         Abstract available
    
    
53. WILT AL, Meya DB, Cresswell FV, Wele A, et al
    CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis.
    J Infect Dis. 2026 Jan 12:jiag032. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Chem

54. ZHANG W, Chen J, Fang M, Song M, et al
    Discovery and Structural Optimization of Spirodioxynaphthalene-Based Mdr1 Efflux Pump Inhibitor to Combat Azole Resistance in Candida albicans.
    J Med Chem. 2026 Jan 14. doi: 10.1021/acs.jmedchem.5c03455.
    PubMed         Abstract available
    
    
55. SINGH S, Ng PS, Lakshmanan U, Mathiyazakan V, et al
    A Series of Pyrazolo-Quinazoline Amines Inhibits the Cytochrome bd Oxidase in Mycobacterium tuberculosis.
    J Med Chem. 2026 Jan 13. doi: 10.1021/acs.jmedchem.5c01616.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

56. ROBERTS B, da Silva AC, Sloan T, Penfold CN, et al
    Clinical isolates from chronic wounds reveal strain-specific, alkyl-quinolone-independent competition in Pseudomonas aeruginosa-Staphylococcus aureus biofilms.
    J Med Microbiol. 2026;75:002118.
    PubMed         Abstract available
    
    
57. SCHOELER S, Theiler T, Mollers M, Olaru ID, et al
    Streptococcus agalactiae colonization in pregnant women: which culture-based detection method is best?
    J Med Microbiol. 2026;75:002115.
    PubMed         Abstract available
    
    
58. YAZGAN Z, Aygun G, Algingil SA, Caliskan R, et al
    Investigation of azole resistance in Aspergillus species isolated from clinical specimens by azole agar screening method.
    J Med Microbiol. 2026;75:002112.
    PubMed         Abstract available
    
    

    
    Lancet

59. LUCKEY A, Balasegaram M, Barbee LA, Batteiger TA, et al
    Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.
    Lancet. 2025 Dec 11:S0140-6736(25)01953-1. doi: 10.1016/S0140-6736(25)01953.
    PubMed         Abstract available
    
    

    
    Nat Med

60. CROWLEY BM, Boshoff HI, Boving A, Tan VY, et al
    Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis.
    Nat Med. 2026 Jan 13. doi: 10.1038/s41591-025-04164.
    PubMed         Abstract available
    
    
61. DONOVAN J, Duc Bang N, Dong HKT, Ho DTN, et al
    Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial.
    Nat Med. 2026 Jan 15. doi: 10.1038/s41591-025-04138.
    PubMed         Abstract available
    
    
62. 
    A low-toxicity linezolid analog has potential for use in all patients with tuberculosis.
    Nat Med. 2026 Jan 15. doi: 10.1038/s41591-025-04188.
    PubMed        
    
    

    
    Nature

63. PIKOULAS A, Morianos I, Nidris V, Hamdy R, et al
    Albumin orchestrates a natural host defence mechanism against mucormycosis.
    Nature. 2026;649:693-702.
    PubMed         Abstract available
    
    

    
    PLoS Genet

64. MACKEY AI, Fraunfelter V, Shaltz S, McCormick J, et al
    Temperature and genetic background drive mobilization of diverse transposable elements in a global human fungal pathogen.
    PLoS Genet. 2026;22:e1011979.
    PubMed         Abstract available
    
    

    
    PLoS Med

65. STANTON TD, Keegan SP, Abdulahi JA, Amulele AV, et al
    Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: A meta-analysis of genome-predicted serotype prevalence to inform potential vaccine coverage.
    PLoS Med. 2026;23:e1004879.
    PubMed         Abstract available
    
    

    
    PLoS One

66. CHO E, Acosta K, Henkin J, Abzalimov R, et al
    Synergistic antifungal effects of botanical extracts against Candida albicans.
    PLoS One. 2026;21:e0340665.
    PubMed         Abstract available
    
    
67. TROOP P, Keam B, Mullen C, Odhiambo JN, et al
    Barriers and facilitators of tuberculosis treatment adherence among nomadic populations in Sub-Saharan Africa: A scoping review protocol.
    PLoS One. 2026;21:e0340307.
    PubMed         Abstract available
    
    
68. ZENG Z, Sathasivam S, Xin J, Zhao H, et al
    Public participation in healthcare safety: A tripartite evolutionary game model with evidence from diverse international cases.
    PLoS One. 2026;21:e0339304.
    PubMed         Abstract available
    
    
69. LANSER DM, Turner A, Pacifici N, Vu K, et al
    Conjugation of a Cryptococcus neoformans-derived metalloprotease to antifungal-loaded PLGA nanoparticles treats neural cryptococcosis in an in vitro model.
    PLoS One. 2026;21:e0340202.
    PubMed         Abstract available
    
    
70. QUAADE ML, Leijon M, Hakhverdyan M, Rasmussen TB, et al
    Association between mink coronavirus (MCoV), Campylobacter spp., and diarrhea in farmed mink (Neogale vison).
    PLoS One. 2026;21:e0341271.
    PubMed         Abstract available
    
    
71. GOPIKRISHNAN M, Doss C GP
    Integrative pan-resistome and transcriptomic characterization reveals differential gene expression signatures in carbapenem-resistant Acinetobacter baumannii: Insights into efflux pump regulation and therapeutic targeting strategies.
    PLoS One. 2026;21:e0340266.
    PubMed         Abstract available
    
    
72. DE ANDRES MONTERO M, Kis L, Vig V, Kocsmar R, et al
    Insights into the pathogenesis and differential diagnosis of clival lesions in an individual from a 16th-century-CE mass grave at Mohacs (Southwestern Hungary).
    PLoS One. 2026;21:e0340762.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

73. MOLOTO K, Newton-Foot M, Dramowski A, Ayala-Montano S, et al
    Carbapenem resistant Klebsiella pneumoniae isolates at a tertiary hospital in Cape Town, South Africa, are dominated by specific local clones rather than previously described international lineages.
    PLoS Pathog. 2026;22:e1013859.
    PubMed         Abstract available
    
    
74. GUPTA S, Matsunaga J, Ratitong B, Manion A, et al
    cGAS-STING dependent type I IFN reduces Leptospira interrogans renal colonization in mice.
    PLoS Pathog. 2026;22:e1013250.
    PubMed         Abstract available
    
    
75. GUAN J, Wang Y, Fu M, Tang L, et al
    EnP1 exploits H2Aub-dependent epigenetic reprogramming to promote microsporidia proliferation in host cells.
    PLoS Pathog. 2026;22:e1013853.
    PubMed         Abstract available
    
    
76. PERSHING NL, Brzozowski RS, Schmidt AK, Faith DR, et al
    A prophage-encoded sRNA limits phage infection of adherent-invasive E. coli.
    PLoS Pathog. 2026;22:e1013836.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

77. TONELLI BA, Youngflesh C, Tingley MW
    An ecological cascade links climatic variability to avian irruptions and zoonotic salmonellosis outbreaks.
    Proc Natl Acad Sci U S A. 2026;123:e2511209123.
    PubMed         Abstract available
    
    
78. TURCOTTE EA, Kim K, Eislmayr KD, Goers L, et al
    Shigella OspF blocks rapid p38-dependent priming of the NAIP-NLRC4 inflammasome.
    Proc Natl Acad Sci U S A. 2026;123:e2510950123.
    PubMed         Abstract available
    
    
79. VELEZ AZ, Radin JN, Kennedy EN, Parsons JB, et al
    The innate immune protein calprotectin ablates the bactericidal activity of beta-lactam antibiotics.
    Proc Natl Acad Sci U S A. 2026;123:e2513462123.
    PubMed         Abstract available
    
    
80. MCDONOUGH LD, Li S, Munsamy-Govender V, Gwin CM, et al
    An activator of a two-component system controls cell separation and intrinsic drug resistance in Mycobacterium tuberculosis.
    Proc Natl Acad Sci U S A. 2026;123:e2519608123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.